BCAR3
Reaktivität: Human, Maus
Wirt: Synthetic
BP, BI
Applikationshinweise
Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Buffer
Lyophilized powder
Lagerung
-20 °C
Informationen zur Lagerung
Shipped at 4°C. Store at -20°C for one year.
Haltbarkeit
12 months
Target
BCAR3
(Breast Cancer Anti-Estrogen Resistance 3 (BCAR3))
Synonyme
NSP2 Peptide, SH2D3B Peptide, AI131758 Peptide, AND-34 Peptide, BCAR3 Peptide, breast cancer anti-estrogen resistance 3 Peptide, breast cancer anti-estrogen resistance 3 L homeolog Peptide, BCAR3 Peptide, Bcar3 Peptide, bcar3 Peptide, bcar3.L Peptide
Hintergrund
NSP2, SH2D3B, Breast cancer anti-estrogen resistance protein 3, Novel SH2-containing protein 2, SH2 domain-containing protein 3B